FdaApplication
NDA 209936
Identifiers
- fda_app_no: NDA209936
Properties
| Property | Value |
|---|---|
| applicant_name | BAYER HEALTHCARE PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2017-09-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ALIQOPA | COPANLISIB DIHYDROCHLORIDE | 60MG/VIAL | POWDER;INTRAVENOUS |
1 product